Stanley Laman Group, Ltd. Schrodinger, Inc. Transaction History

Stanley Laman Group, Ltd.

$652 Million
Q4 2024

A detailed history of Stanley Laman Group, Ltd. transactions in Schrodinger, Inc. stock. As of the latest transaction made, Stanley Laman Group, Ltd. holds 159,469 shares of SDGR stock, worth $4.17 Million. This represents 0.47% of its overall portfolio holdings.

Number of Shares

159,469

Previous 197,668 19.32%

Holding current value

$4.17 Million

Previous $3.67 Million 16.09%

% of portfolio

0.47%

Previous 0.57%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 29, 2025	SELL	$16.98 - $22.57 $648,619 - $862,151	-38,199 Reduced 19.32%	159,469 $3.08 Million
Q3 2024 Oct 21, 2024	SELL	$18.05 - $24.02 $605,685 - $806,015	-33,556 Reduced 14.51%	197,668 $3.67 Million
Q2 2024 Jul 18, 2024	SELL	$18.65 - $28.5 $412,724 - $630,705	-22,130 Reduced 8.73%	231,224 $4.47 Million
Q1 2024 Apr 17, 2024	BUY	$24.74 - $35.13 $138,222 - $196,271	5,587 Added 2.25%	253,354 $6.84 Million
Q4 2023 Feb 02, 2024	SELL	$21.62 - $37.21 $244,651 - $421,068	-11,316 Reduced 4.37%	247,767 $8.87 Million
Q3 2023 Oct 16, 2023	SELL	$27.34 - $55.37 $184,025 - $372,695	-6,731 Reduced 2.53%	259,083 $7.32 Million
Q2 2023 Aug 08, 2023	SELL	$26.1 - $49.92 $351,384 - $672,072	-13,463 Reduced 4.82%	265,814 $13.3 Million
Q1 2023 Apr 17, 2023	SELL	$18.09 - $27.61 $936,483 - $1.43 Million	-51,768 Reduced 15.64%	279,277 $7.35 Million
Q4 2022 Jan 19, 2023	BUY	$16.24 - $26.38 $473,558 - $769,240	29,160 Added 9.66%	331,045 $0
Q3 2022 Oct 18, 2022	BUY	$23.95 - $34.71 $6.12 Million - $8.86 Million	255,362 Added 548.89%	301,885 $7.54 Million
Q2 2022 Aug 08, 2022	BUY	$21.39 - $35.9 $995,126 - $1.67 Million	46,523 New	46,523 $1.23 Million

Others Institutions Holding SDGR

# of Institutions

241

Shares Held

61.3M

Call Options Held

726K

Put Options Held

329K

View Full List

About Schrodinger, Inc.

Ticker SDGR
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 62,028,400
Market Cap $1.62B
Description
Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences i...

More about SDGR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stanley Laman Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Stanley Laman Group, Ltd. with notifications on news.

Account

Stanley Laman Group, Ltd. Schrodinger, Inc. Transaction History